PACIRA PHARMACEUTICALS INC's ticker is and the CUSIP is 695127AB6.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $4,402,000 | -0.1% | 1,233,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $4,407,000 | -24.8% | 1,233,000 | -17.8% | 0.00% | 0.0% |
| Q3 2014 | $5,858,000 | +4.7% | 1,500,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $5,597,000 | +31.2% | 1,500,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $4,267,000 | – | 1,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EQUITEC SPECIALISTS, LLC | 3,000,000 | $4,524,000 | 1.31% |
| Myriad Asset Management Ltd. | 10,000,000 | $14,880,000 | 0.95% |
| WHITEBOX ADVISORS LLC | 11,350,000 | $17,117,000 | 0.71% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,743,000 | $32,797,000 | 0.49% |
| MIZUHO SECURITIES USA LLC | 3,500,000 | $5,275,000 | 0.44% |
| Verition Fund Management LLC | 1,160,000 | $1,755,000 | 0.19% |
| CSS LLC/IL | 1,500,000 | $2,245,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 982,000 | $1,473,000 | 0.05% |
| Citadel Advisors | 30,050,000 | $45,358,000 | 0.05% |
| LAZARD ASSET MANAGEMENT LLC | 9,000,000 | $13,618,000 | 0.03% |